倍性作为顺铂治疗的头颈部晚期鳞状细胞癌的预后指标。
Ploidy as a prognostic indicator in end stage squamous cell carcinoma of the head and neck region treated with cisplatinum.
作者信息
Cooke L D, Cooke T G, Bootz F, Forster G, Helliwell T R, Spiller D, Stell P M
机构信息
Department of Otorhinolaryngology, University of Liverpool, UK.
出版信息
Br J Cancer. 1990 May;61(5):759-62. doi: 10.1038/bjc.1990.169.
Abstract
We measured tumour cellular DNA in 102 patients entered into two phase III trials of chemotherapy for end stage squamous carcinoma of the head and neck. The median survival of untreated patients with aneuploid tumours was 55 days compared with 224 days for patients treated with cisplatinum. This difference was highly significant. In contrast the median survival of untreated patients with diploid tumours was 74 days compared with 118 days for treated patients. Although this difference is statistically significant, the increased survival of 6 weeks is of no clinical benefit compared with the prolongation of survival of 6 months in patients with aneuploid tumours. Multivariate analysis showed that the significant predictors of survival were Karnofsky status, response to chemotherapy and ploidy.
摘要
我们对102例进入两项晚期头颈部鳞状细胞癌化疗III期试验的患者的肿瘤细胞DNA进行了检测。非整倍体肿瘤的未治疗患者的中位生存期为55天，而接受顺铂治疗的患者为224天。这种差异具有高度显著性。相比之下，二倍体肿瘤的未治疗患者的中位生存期为74天，接受治疗的患者为118天。虽然这种差异具有统计学意义，但与非整倍体肿瘤患者生存期延长6个月相比，二倍体肿瘤患者生存期仅延长6周并无临床益处。多变量分析表明，生存的显著预测因素为卡诺夫斯基状态、化疗反应和倍性。
相似文献
1
Ploidy as a prognostic indicator in end stage squamous cell carcinoma of the head and neck region treated with cisplatinum.倍性作为顺铂治疗的头颈部晚期鳞状细胞癌的预后指标。
Br J Cancer. 1990 May;61(5):759-62. doi: 10.1038/bjc.1990.169.
2
Morphometric analysis, ploidy and response to chemotherapy in squamous carcinomas of the head and neck.头颈部鳞状细胞癌的形态计量分析、倍性及对化疗的反应
Pathol Res Pract. 1989 Nov;185(5):755-9. doi: 10.1016/S0344-0338(89)80233-X.
3
The significance of DNA flow cytometry in predicting survival and delayed clinical manifestation of occult lymph node metastasis to the untreated neck in patients with oral squamous cell carcinoma.DNA流式细胞术在预测口腔鳞状细胞癌患者未治疗颈部隐匿性淋巴结转移的生存率及延迟临床表现方面的意义。
J Craniomaxillofac Surg. 1998 Dec;26(6):405-10. doi: 10.1016/s1010-5182(98)80076-0.
4
Prognostic importance of cellular DNA content in head-and-neck squamous-cell cancers. A comparison of retrospective and prospective series.头颈部鳞状细胞癌中细胞DNA含量的预后重要性。回顾性和前瞻性系列研究的比较。
Int J Cancer. 1991 Jan 2;47(1):31-7. doi: 10.1002/ijc.2910470107.
5
A phase II study of cisplatinum versus cisplatinum + nifedipine in end-stage carcinoma of the head and neck.
Clin Otolaryngol Allied Sci. 1992 Dec;17(6):501-4. doi: 10.1111/j.1365-2273.1992.tb01705.x.
6
A randomized phase III trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-fluoro-uracil in end-stage head and neck cancer.
Acta Otolaryngol. 1987 May-Jun;103(5-6):519-28.
7
[Analysis of DNA ploidy using fresh frozen tissues from head and neck squamous cell carcinomas].[使用头颈部鳞状细胞癌新鲜冷冻组织进行DNA倍体分析]
Nihon Jibiinkoka Gakkai Kaiho. 1994 Feb;97(2):254-9. doi: 10.3950/jibiinkoka.97.254.
8
Analysis of DNA ploidy using fresh frozen tissues of head and neck squamous cell carcinomas.利用头颈部鳞状细胞癌新鲜冷冻组织进行DNA倍体分析。
Auris Nasus Larynx. 1997 Apr;24(2):193-8. doi: 10.1016/S0385-8146(96)00018-1.
9
Prognostic factors in head and neck cancer: histologic grading, DNA ploidy, and nodal status.头颈癌的预后因素：组织学分级、DNA倍体和淋巴结状态。
Head Neck. 1991 Nov-Dec;13(6):477-87. doi: 10.1002/hed.2880130603.
10
Nuclear DNA content using computerized image cytometry of squamous cell carcinomas of the head and neck.使用计算机图像细胞术检测头颈部鳞状细胞癌的核DNA含量。
J Laryngol Otol. 1997 Jan;111(1):43-7. doi: 10.1017/s0022215100136394.
引用本文的文献
1
The clinical application of DNA content and kinetic parameters in the treatment of patients with squamous cell carcinomas of the head and neck.DNA含量及动力学参数在头颈部鳞状细胞癌患者治疗中的临床应用
Cancer Metastasis Rev. 1996 Mar;15(1):133-41. doi: 10.1007/BF00049492.
2
The nature of the head and neck cancer.头颈癌的性质。
Eur Arch Otorhinolaryngol. 1993;250(3):127-32. doi: 10.1007/BF00171696.
3
Influence of preoperative radiotherapy on DNA ploidy in squamous cell carcinomas of the oesophagus.术前放疗对食管鳞状细胞癌DNA倍体的影响。
Gut. 1993 Aug;34(8):1086-90. doi: 10.1136/gut.34.8.1086.
4
Cellular DNA content and prognosis in surgically treated squamous carcinoma of the larynx.手术治疗的喉鳞状细胞癌的细胞DNA含量与预后
Br J Cancer. 1991 Jun;63(6):1018-20. doi: 10.1038/bjc.1991.221.
5
Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells.葡萄糖饥饿与酸中毒：对小鼠肿瘤细胞实验性转移潜能、DNA含量及甲氨蝶呤耐药性的影响
Br J Cancer. 1991 Oct;64(4):663-70. doi: 10.1038/bjc.1991.378.
6
Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.通过体内溴脱氧尿苷掺入和流式细胞术测量头颈部鳞状细胞癌的肿瘤生长速率。
Br J Cancer. 1992 May;65(5):698-702. doi: 10.1038/bjc.1992.147.
本文引用的文献
1
Reporting results of cancer treatment.癌症治疗结果报告。
Cancer. 1981 Jan 1;47(1):207-14. doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6.
2
DNA and its synthesis in individual tumor cells from human upper respiratory tract squamous cell carcinomas.人类上呼吸道鳞状细胞癌单个肿瘤细胞中的DNA及其合成
Laryngoscope. 1980 Jul;90(7 Pt 1):1209-24. doi: 10.1288/00005537-198007000-00017.
3
Cellular DNA amounts of squamous cell carcinomas of the head and neck region in relation to prognosis.
Laryngoscope. 1982 Sep;92(9 Pt 1):1064-9.
4
Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma.细胞DNA含量作为不可切除神经母细胞瘤婴儿化疗反应的预测指标。
N Engl J Med. 1984 Jul 26;311(4):231-5. doi: 10.1056/NEJM198407263110405.
5
Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.使用流式细胞术分析石蜡包埋病理材料细胞DNA含量的方法。
J Histochem Cytochem. 1983 Nov;31(11):1333-5. doi: 10.1177/31.11.6619538.
6
Prognostic impact of ploidy level in carcinoma of the cervix.宫颈癌细胞倍体水平的预后影响
Am J Clin Oncol. 1984 Oct;7(5):475-80. doi: 10.1097/00000421-198410000-00016.
7
Flow cytometry in clinical cancer research.临床癌症研究中的流式细胞术。
Cancer Res. 1983 Sep;43(9):3982-97.
8
Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading.
Cytometry. 1985 Sep;6(5):461-70. doi: 10.1002/cyto.990060511.
9
The influence of tumour cell DNA abnormalities on survival in colorectal cancer.肿瘤细胞DNA异常对结直肠癌生存的影响。
Br J Surg. 1985 Oct;72(10):828-30. doi: 10.1002/bjs.1800721018.
10
Malignant potentiality of squamous cell carcinoma of the esophagus predictable by DNA analysis.通过DNA分析可预测食管鳞状细胞癌的恶性潜能。
Cancer. 1986 May 1;57(9):1810-4. doi: 10.1002/1097-0142(19860501)57:9<1810::aid-cncr2820570917>3.0.co;2-j.
Zotero 插件